Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) is one of 1,068 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We ...

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $11.29 and traded as high as $13.45.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

Stevanato's 2024 revenue hits €1.1B, driven by biopharma growth! Discover how facility expansions & rising demand are ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

Benitec Biopharma Inc.’s BNTC share price has surged by 11.39%, which has investors questioning if this is right time to sell ...

In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate). BEDMINSTER, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (the "Company"), a biopharmaceutical company dedicated to ...

There's a perfectly good answer: Like so many other technology and biopharma stocks of its ilk and age, Recursion soared on hype before the world was fully ready to embrace its solution.